Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Zeitschrift Fur Rheumatologie
|
June 30, 2018
[Lupus nephritis]
S Melderis, T Wiech, C Iking-Konert, et al.
Annals of the Rheumatic Diseases
|
March 15, 2006
"Bubbles in the brain": an unusual complication of dermatomyositis
C Iking-Konert, B Ostendorf, G Jung, et al.
Immunology
|
December 21, 2000
Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation
M Radsak, C Iking-Konert, S Stegmaier, et al.
Zeitschrift Fur Rheumatologie
|
June 10, 2010
[Novel approach for the early detection of inflammatory rheumatic diseases in the population using a mobile screening unit]
J Heinert, C Iking-Konert, M Blumenroth, et al.
Annals of the Rheumatic Diseases
|
September 4, 2004
Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis
B Ostendorf, C Iking-Konert, K Kurz, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 23, 2000
Differentiation of polymorphonuclear neutrophils in patients with systemic infections and chronic inflammatory diseases: evidence of prolonged life span and de novo synthesis of fibronectin
C Wagner, M Pioch, C Meyer, et al.
Infection and Immunity
|
July 12, 2001
Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS
D Kuck, B Kolmerer, C Iking-Konert, et al.
Kidney International
|
December 12, 2001
Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells
C Iking-Konert, S Vogt, M Radsak, et al.
Annals of the Rheumatic Diseases
|
December 29, 2010
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
Gerd R Burmester, E Feist, H Kellner, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 21, 2001
Transdifferentiation of polymorphonuclear neutrophils: acquisition of CD83 and other functional characteristics of dendritic cells
C Iking-Konert, C Csekö, C Wagner, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Zeitschrift Fur Rheumatologie
|
June 30, 2018
[Lupus nephritis]
S Melderis, T Wiech, C Iking-Konert, et al.
Annals of the Rheumatic Diseases
|
March 15, 2006
"Bubbles in the brain": an unusual complication of dermatomyositis
C Iking-Konert, B Ostendorf, G Jung, et al.
Immunology
|
December 21, 2000
Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation
M Radsak, C Iking-Konert, S Stegmaier, et al.
Zeitschrift Fur Rheumatologie
|
June 10, 2010
[Novel approach for the early detection of inflammatory rheumatic diseases in the population using a mobile screening unit]
J Heinert, C Iking-Konert, M Blumenroth, et al.
Annals of the Rheumatic Diseases
|
September 4, 2004
Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis
B Ostendorf, C Iking-Konert, K Kurz, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 23, 2000
Differentiation of polymorphonuclear neutrophils in patients with systemic infections and chronic inflammatory diseases: evidence of prolonged life span and de novo synthesis of fibronectin
C Wagner, M Pioch, C Meyer, et al.
Infection and Immunity
|
July 12, 2001
Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS
D Kuck, B Kolmerer, C Iking-Konert, et al.
Kidney International
|
December 12, 2001
Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells
C Iking-Konert, S Vogt, M Radsak, et al.
Annals of the Rheumatic Diseases
|
December 29, 2010
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
Gerd R Burmester, E Feist, H Kellner, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 21, 2001
Transdifferentiation of polymorphonuclear neutrophils: acquisition of CD83 and other functional characteristics of dendritic cells
C Iking-Konert, C Csekö, C Wagner, et al.
Page
of 4